• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三七总皂苷 R1 通过上调 H9c2 细胞中 miR-132 对缺氧/复氧剥夺诱导的损伤起保护作用。

Notoginsenoside R1 protects hypoxia-reoxygenation deprivation-induced injury by upregulation of miR-132 in H9c2 cells.

机构信息

School of Medicine, Quzhou College of Technology, Quzhou, Zhejiang, China.

Department of Pharmacy, Jiangshan Hospital of Traditional Chinese Medicine, Quzhou, Zhejiang, China.

出版信息

Hum Exp Toxicol. 2021 Dec;40(12_suppl):S29-S38. doi: 10.1177/09603271211025589. Epub 2021 Jul 2.

DOI:10.1177/09603271211025589
PMID:34212764
Abstract

BACKGROUND

Myocardial ischemia/reperfusion injury (IRI) is a common perioperative complication of heart and great vessels surgery, aggravating the original myocardial damage and seriously affecting the postoperative recovery of cardiac function. The aim of this study was to reveal the functional effects and potential mechanisms of notoginsenoside R1 (NG-R1) in myocardial cells injured by hypoxia-reoxygenation (H/R).

METHODS

The rat cardiomyocyte line H9c2 was subjected to H/R with or without NG-R1 treatment. The levels of miR-132 and HBEGF in the cell were altered by microRNA or short-hairpin RNA transfection. Cell viability, apoptosis, lactate dehydrogenase (LDH) and malondialdehyde (MDA) were monitored. Dual luciferin was used to detect the relationship between miR-132 and HBEGF.

RESULTS

NG-R1 20 μM) had no impact on H9c2 cells, but cell viability was significantly reduced at 80 μM. NG-R1 (20 μM) protected H9c2 cells against H/R-induced cell damage, accompanied by increased cell viability, reduced cell apoptosis, and downregulation of LDH and MDA. Furthermore, the level of miR-132 was decreased in response to H/R exposure but then increased after NG-R1 treatment. When miR-132 was overexpressed, H/R-induced cell damage could be recovered. Downregulation of miR-132 limited the protective effect of NG-R1 on H/R damage. We also found that HBEGF was a direct target of miR-132. The expression of HBEGF was increased upon H/R damage, and this increase was reversed after NG-R1 treatment.

CONCLUSIONS

This study demonstrated that NG-R1 markedly protected H9c2 cells against H/R-induced damage via upregulation of miR-132 and downregulation of its target protein HBEGF.

摘要

背景

心肌缺血/再灌注损伤(IRI)是心脏和大血管手术围手术期常见的并发症,加重了原有心肌损伤,严重影响了心脏功能的术后恢复。本研究旨在揭示三七皂苷 R1(NG-R1)在缺氧/复氧(H/R)损伤心肌细胞中的功能作用及潜在机制。

方法

采用 H/R 处理大鼠心肌细胞系 H9c2,并用 NG-R1 处理。通过 microRNA 或短发夹 RNA 转染改变细胞中 miR-132 和 HBEGF 的水平。监测细胞活力、凋亡、乳酸脱氢酶(LDH)和丙二醛(MDA)。用双荧光素酶检测 miR-132 和 HBEGF 之间的关系。

结果

20 μM 的 NG-R1 对 H9c2 细胞没有影响,但 80 μM 的 NG-R1 则显著降低了细胞活力。NG-R1(20 μM)可保护 H9c2 细胞免受 H/R 诱导的细胞损伤,表现为细胞活力增加、细胞凋亡减少以及 LDH 和 MDA 降低。此外,H/R 暴露后 miR-132 水平降低,而 NG-R1 处理后则升高。当 miR-132 过表达时,H/R 诱导的细胞损伤可得到恢复。下调 miR-132 则限制了 NG-R1 对 H/R 损伤的保护作用。我们还发现,HBEGF 是 miR-132 的直接靶标。H/R 损伤后 HBEGF 表达增加,而 NG-R1 处理后则逆转。

结论

本研究表明,NG-R1 通过上调 miR-132 和下调其靶蛋白 HBEGF,显著保护 H9c2 细胞免受 H/R 诱导的损伤。

相似文献

1
Notoginsenoside R1 protects hypoxia-reoxygenation deprivation-induced injury by upregulation of miR-132 in H9c2 cells.三七总皂苷 R1 通过上调 H9c2 细胞中 miR-132 对缺氧/复氧剥夺诱导的损伤起保护作用。
Hum Exp Toxicol. 2021 Dec;40(12_suppl):S29-S38. doi: 10.1177/09603271211025589. Epub 2021 Jul 2.
2
Notoginsenoside R1 protects oxygen and glucose deprivation-induced injury by upregulation of miR-21 in cardiomyocytes.三七皂苷 R1 通过上调心肌细胞 miR-21 保护缺氧/葡萄糖剥夺诱导的损伤。
J Cell Biochem. 2019 Jun;120(6):9181-9192. doi: 10.1002/jcb.28194. Epub 2018 Dec 14.
3
MicroRNA-760-mediated low expression of DUSP1 impedes the protective effect of NaHS on myocardial ischemia-reperfusion injury.微小 RNA-760 介导的 DUSP1 低表达抑制了 NaHS 对心肌缺血再灌注损伤的保护作用。
Biochem Cell Biol. 2020 Jun;98(3):378-385. doi: 10.1139/bcb-2019-0310. Epub 2020 May 15.
4
Inhibition of miR-148b ameliorates myocardial ischemia/reperfusion injury via regulation of Wnt/β-catenin signaling pathway.抑制 miR-148b 通过调控 Wnt/β-catenin 信号通路改善心肌缺血/再灌注损伤。
J Cell Physiol. 2019 Aug;234(10):17757-17766. doi: 10.1002/jcp.28401. Epub 2019 Feb 28.
5
Notoginsenoside R1 protects against myocardial ischemia/reperfusion injury in mice via suppressing TAK1-JNK/p38 signaling.三七总皂苷 R1 通过抑制 TAK1-JNK/p38 信号通路保护小鼠心肌缺血/再灌注损伤。
Acta Pharmacol Sin. 2023 Jul;44(7):1366-1379. doi: 10.1038/s41401-023-01057-y. Epub 2023 Jan 31.
6
HSP70 protects H9C2 cells from hypoxia and reoxygenation injury through STIM1/IP3R.热休克蛋白 70 通过 STIM1/IP3R 保护 H9C2 细胞免受低氧和再氧合损伤。
Cell Stress Chaperones. 2022 Sep;27(5):535-544. doi: 10.1007/s12192-022-01290-0. Epub 2022 Jul 16.
7
Dexmedetomidine Attenuates Hypoxia/Reoxygenation Injury of H9C2 Myocardial Cells by Upregulating miR-146a Expression via the MAPK Signal Pathway.右美托咪定通过 MAPK 信号通路上调 miR-146a 表达减轻 H9C2 心肌细胞缺氧/复氧损伤。
Pharmacology. 2022;107(1-2):14-27. doi: 10.1159/000506814. Epub 2021 Oct 29.
8
MiR-21 mediates the protection of kaempferol against hypoxia/reoxygenation-induced cardiomyocyte injury via promoting Notch1/PTEN/AKT signaling pathway.miR-21 通过促进 Notch1/PTEN/AKT 信号通路介导山奈酚对低氧/复氧诱导的心肌细胞损伤的保护作用。
PLoS One. 2020 Nov 5;15(11):e0241007. doi: 10.1371/journal.pone.0241007. eCollection 2020.
9
Long Noncoding RNA Taurine-Upregulated Gene 1 Knockdown Protects Cardiomyocytes Against Hypoxia/Reoxygenation-induced Injury Through Regulating miR-532-5p/Sox8 Axis.长链非编码RNA牛磺酸上调基因1敲低通过调控miR-532-5p/Sox8轴保护心肌细胞免受缺氧/复氧诱导的损伤。
J Cardiovasc Pharmacol. 2020 Nov;76(5):556-563. doi: 10.1097/FJC.0000000000000895.
10
miR-181c-5p Exacerbates Hypoxia/Reoxygenation-Induced Cardiomyocyte Apoptosis via Targeting PTPN4.miR-181c-5p 通过靶向 PTPN4 加剧缺氧/复氧诱导的心肌细胞凋亡。
Oxid Med Cell Longev. 2019 Apr 17;2019:1957920. doi: 10.1155/2019/1957920. eCollection 2019.

引用本文的文献

1
Potential Role of Natural Antioxidants in Countering Reperfusion Injury in Acute Myocardial Infarction and Ischemic Stroke.天然抗氧化剂在对抗急性心肌梗死和缺血性中风再灌注损伤中的潜在作用
Antioxidants (Basel). 2023 Sep 13;12(9):1760. doi: 10.3390/antiox12091760.
2
Notoginsenoside R1 protects against myocardial ischemia/reperfusion injury in mice via suppressing TAK1-JNK/p38 signaling.三七总皂苷 R1 通过抑制 TAK1-JNK/p38 信号通路保护小鼠心肌缺血/再灌注损伤。
Acta Pharmacol Sin. 2023 Jul;44(7):1366-1379. doi: 10.1038/s41401-023-01057-y. Epub 2023 Jan 31.
3
Research progress on effects of traditional Chinese medicine on myocardial ischemia-reperfusion injury: A review.
中药对心肌缺血再灌注损伤影响的研究进展:综述
Front Pharmacol. 2022 Dec 6;13:1055248. doi: 10.3389/fphar.2022.1055248. eCollection 2022.
4
Pharmacological properties and mechanisms of Notoginsenoside R1 in ischemia-reperfusion injury.三七总皂苷 R1 在缺血再灌注损伤中的药理学特性及作用机制。
Chin J Traumatol. 2023 Jan;26(1):20-26. doi: 10.1016/j.cjtee.2022.06.008. Epub 2022 Jul 3.
5
Notoginsenoside R1-loaded mesoporous silica nanoparticles targeting the site of injury through inflammatory cells improves heart repair after myocardial infarction.载notoginsenoside R1 的介孔硅纳米粒通过炎症细胞靶向损伤部位促进心肌梗死后的心脏修复。
Redox Biol. 2022 Aug;54:102384. doi: 10.1016/j.redox.2022.102384. Epub 2022 Jun 24.
6
Antifatigue Effect of Leaves Fermented With Microorganisms: and Evaluation.微生物发酵树叶的抗疲劳作用及评价
Front Nutr. 2022 Feb 22;9:824525. doi: 10.3389/fnut.2022.824525. eCollection 2022.
7
Sevoflurane protects against cerebral ischemia/reperfusion injury via microrna-30c-5p modulating homeodomain-interacting protein kinase 1.七氟醚通过 microRNA-30c-5p 调控同源盒相互作用蛋白激酶 1 发挥对脑缺血再灌注损伤的保护作用。
Bioengineered. 2021 Dec;12(2):11858-11871. doi: 10.1080/21655979.2021.1999551.